GOT1 and familial pancreatic carcinoma: GOT1 is closely associated with cancer, and its high expression can promote the development of tumors such as pancreatic cancer[5], colorectal cancer[6], and breast cancer[7], or as a potential biomarker such as a diagnostic marker for prostate cancer[8] or a prognostic marker for acute myeloid leukemia[9].